Affiliation:
1. Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China
Abstract
Abstract:
As a major cause of various cardiovascular diseases, the prevalence of hypertension
has been increasing in the past 30 years, leading to significant socioeconomic and health burdens.
Obesity is one of the major risk factors for hypertension. Body mass index (BMI) is the
most used anthropometric index to measure obesity in clinical practice and to assess the risk of
obesity-related diseases. However, obesity is a heterogeneous disease, and the accumulation of
fat in different body regions leads to differences in cardiovascular and metabolic risks. BMI only
reflects the overall obesity but does not consider the distribution of fat and muscle mass. The
limitation of BMI makes it insufficient to assess the risk of hypertension attributed to obesity. In
addition, waist circumference is an easily obtainable anthropometric index to evaluate abdominal
fat distribution. High waist circumference is an independent risk factor for various cardiovascular
diseases and all-cause mortality regardless of BMI. Preliminary data indicate that
waist circumference is significantly associated with the risk of hypertension at different BMI
levels. However, routine measurement of waist circumference is currently not required in current
clinical guidelines or is only recommended for obese populations, indicating an insufficient
understanding of waist circumference. In this review, we summarize the measurement methods
and diagnostic thresholds of waist circumference for abdominal obesity, the trend of central
obesity prevalence, the superiority of waist circumference over other anthropometric indices,
and recent cross-sectional and longitudinal studies on the association between obesity and hypertension.
Funder
Nanjing Medical University, China
Publisher
Bentham Science Publishers Ltd.
Reference90 articles.
1. Whelton P.K.; Carey R.M.; Aronow W.S.; 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation 2018,138(17),e426-e483
2. Umemura S.; Arima H.; Arima S.; The japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res 2019,42(9),1235-1481
3. Williams B.; Mancia G.; Spiering W.; 2018 practice guidelines for the management of arterial hypertension of the european society of hypertension and the European society of cardiology: ESH/ESC task force for the management of arterial hypertension. J Hypertens 2018,36(12),2284-2309
4. Unger T.; Borghi C.; Charchar F.; 2020 international society of hypertension global hypertension practice guidelines. Hypertension 2020,75(6),1334-1357
5. Wang J.G.; Zhang W.; Li Y.; Liu L.; Hypertension in China: Epidemiology and treatment initiatives. Nat Rev Cardiol 2023,20(8),531-545